Izumerogant

Overview

Izumerogant (IMU-935) is an orally active RORγ/DHODH dual inhibitor with IC 50 s of 10 and 98 nM against RORγ and DHODH . Izumerogant efficiently blocks the replication of SARS-CoV-2, HCMV and HAdV5 with EC 50 values between 3.6 and 17 nM. Izumerogant can be used for researching antiviral properties.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Viral Infection | Products > Disease Areas > Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > ROR | Products > Signaling Pathways > Dihydroorotate Dehydrogenase | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > CMV

Product Information

• Catalog No.: HY-152851
• CAS No.: 2299252-72-3
• Molecular Formula: C22H18ClF4N5O2
• Molecular Weight: 495.86
• Purity: 99.95%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source